Skip to content

Non-randomised trial, 1990

Does suppressing ovulation help patients with porphyria attacks related to the menstrual cycle?

There was weak evidence of benefit - attacks fell from 7 to 3 median, but this difference was not quite statistically significant. Patients with the strongest menstrual cycle-attack link benefited most.

Early or limited evidence 7 patients with acute intermittent porphyria experiencing menstrual-related attacks

What they did

7 patients with acute intermittent porphyria experiencing menstrual-related crises were monitored for approximately one year before and during treatment with buserelin, a hormone injection that suppresses ovulation. Researchers tracked the number and timing of attacks, hormone levels, and porphyrin excretion.

What they found

The median number of attacks fell from seven during baseline to three during treatment, but this difference was not quite statistically significant (p = 0.06). Response varied between patients, with those whose attacks were most strongly tied to their menstrual cycle having the most benefit. All patients stopped menstruating and had suppressed estrogen and progesterone levels.

What it means for you

This is for a very rare metabolic disorder (porphyria), not typical PMS. The evidence of benefit was weak because the statistical difference was borderline (p = 0.06). Only 7 patients were studied. For patients whose porphyria crises are clearly linked to their menstrual cycle, ovulation suppression might help, but more evidence is needed.

7

patients with menstrual-related porphyria

7 to 3

median attacks before and during treatment

0.06

p-value (not statistically significant)

About the study

Original title
LHRH analogue treatment for the prevention of premenstrual attacks of acute porphyria
Authors
Herrick AL, McColl KE, Wallace AM et al.
Journal
The Quarterly journal of medicine
Year
1990
Study design
Non-randomised trial
What was tested
Buserelin (LHRH analogue injection to suppress ovulation)

Topics